Division Director at Division of Pharmacometrics, Office of Clinical Pharmacology
US Food & Drug Administration
Dr. Hao Zhu is the division director of the Division of Pharmacometrics, Office of Clinical Pharmacology, Office of Translational Science, Center of Drug Evaluation and Research, U.S. Food and Drug Administration. Dr. Zhu received his Ph.D. in pharmaceutical sciences and Master in statistics from the University of Florida. He started his career in modeling and simulation teams in Johnson & Johnson and Bristol-Myers-Squibb. He joined FDA as a pharmacometrics reviewer more than 17 years ago. Dr. Zhu has been a clinical pharmacology team leader for more than 6 years and a QT-IRT scientific lead for 2 years. Then he worked as the deputy division director at the division of Pharmacometrics. His division reviews the pharmacometrics related submissions and supports pharmacometrics-related policy development across CDER.
Disclosure information not submitted.
Symposium 4: Advances in Improving Pediatric Therapeutic Response
Sunday, September 8, 2024
3:30 PM – 5:00 PM ET
2 - Model-informed Drug Development for Pediatric Patients With Psychiatric Disorders
Sunday, September 8, 2024
3:30 PM – 5:00 PM ET